The G-protein bile acid receptor 1 (GPBAR1) has emerged in the last decade as prominent target for the treatment of metabolic and inflammatory diseases including type 2 diabetes, obesity, and non-alcoholic steatohepatitis. The gene discussed is GPBAR1; the disease is obesity due to melanocortin 4 receptor deficiency.